Gliclazide 80mg + Metformin 500mg is a combination oral antidiabetic medication designed to help manage type 2 diabetes mellitus. Gliclazide, a sulfonylurea, works by stimulating insulin release from the pancreatic beta cells, while Metformin, a biguanide, improves insulin sensitivity and reduces hepatic glucose production. Together, they provide effective glycemic control, helping maintain blood sugar levels within the normal range. This combination is suitable for patients whose blood sugar is not adequately controlled with diet, exercise, and either drug alone. The formulation is available in convenient tablet form, ensuring easy dosing and compliance. Regular use under medical supervision can reduce the risk of diabetes-related complications, including neuropathy, retinopathy, and cardiovascular issues.
